| 02/05/2023 07:56:14 |
Suspension of Trading Pending 2022 Annual Report |
Download |
| 02/05/2023 07:30:02 |
Suspension - Roquefort Therapeutics plc |
Download |
| 13/03/2023 07:30:04 |
Confirmation of No Exposure to Silicon Valley Bank |
Download |
| 08/03/2023 07:00:06 |
Creation of New Novel Family of mRNA Therapeutics |
Download |
| 06/03/2023 07:00:02 |
Formation of Scientific Advisory Board |
Download |
| 01/03/2023 07:00:12 |
Company Presentation |
Download |
| 21/02/2023 07:00:08 |
Investor Presentation |
Download |
| 20/02/2023 07:00:03 |
Randox Licence and Royalty Agreement |
Download |
| 24/01/2023 07:00:03 |
MDK Oncology Antibodies Demonstrate In-Vivo Safety |
Download |
| 18/01/2023 08:36:18 |
Holding(s) in Company |
Download |
| 16/01/2023 07:00:06 |
Appointment of Auditor |
Download |
| 09/01/2023 07:00:01 |
Operations Update |
Download |
| 05/12/2022 08:07:52 |
Presentation of Midkine Oligonucleotide Program |
Download |
| 01/12/2022 14:00:06 |
Resignation of Auditor |
Download |
| 25/10/2022 07:00:06 |
Midkine Antibody Program - Festival of Biologics |
Download |
| 11/10/2022 07:00:17 |
ROQ Presents Study Results at the ESGCT Conference |
Download |
| 28/09/2022 07:00:12 |
Director/PDMR Shareholding |
Download |
| 26/09/2022 14:30:08 |
Director/PDMR Shareholding |
Download |
| 23/09/2022 07:00:06 |
Interim Results to 30 June 2022 |
Download |
| 16/09/2022 08:00:04 |
Investor Presentation |
Download |
| 16/09/2022 07:01:01 |
Board and Management Appointments |
Download |
| 16/09/2022 07:00:04 |
Acquisition Completion, Admission & Voting Rights |
Download |
| 15/09/2022 12:26:17 |
Notice of Admission |
Download |
| 13/09/2022 11:08:19 |
Publication of Prospectus |
Download |
| 11/08/2022 07:00:12 |
Pre-clinical Program & Transaction Update |
Download |
| 20/07/2022 07:00:09 |
Appointment of Joint Broker |
Download |
| 15/07/2022 07:00:05 |
Commencement of Trading on US OTCQB Venture Market |
Download |
| 04/07/2022 16:57:51 |
Director/PDMR Shareholding |
Download |
| 30/06/2022 16:38:56 |
Director/PDMR Shareholding |
Download |
| 30/06/2022 10:30:05 |
Result of AGM |
Download |
| 23/06/2022 07:00:03 |
Update on Acquisition of Oncogeni and Placing |
Download |
| 22/06/2022 16:42:01 |
Issue of Warrants |
Download |
| 22/06/2022 10:32:34 |
Investor Presentation |
Download |
| 22/06/2022 09:05:48 |
Second Price Monitoring Extn |
Download |
| 22/06/2022 09:00:38 |
Price Monitoring Extension |
Download |
| 22/06/2022 07:00:05 |
Proposed Acquisition of Oncogeni Limited & Placing |
Download |
| 13/06/2022 07:00:07 |
Notice of AGM - Correction |
Download |
| 07/06/2022 07:00:08 |
Pre-clinical Update |
Download |
| 07/06/2022 07:00:08 |
Notice of AGM |
Download |
| 11/05/2022 07:00:02 |
Annual Report & Financial Statements |
Download |
| 20/04/2022 07:00:04 |
Non-Executive Director Appointment |
Download |
| 05/04/2022 07:00:05 |
Board Appointment |
Download |
| 22/03/2022 08:08:00 |
Holding(s) in Company |
Download |
| 21/03/2022 09:34:58 |
Investor Presentation |
Download |
| 21/03/2022 07:00:10 |
Patent Filed – New Drug Class Targeting Midkine |
Download |
| 08/03/2022 07:54:13 |
Holding(s) in Company |
Download |
| 14/02/2022 07:00:08 |
Appointment of Strategic & Scientific Advisor |
Download |
| 08/02/2022 11:35:22 |
Holding(s) in Company |
Download |
| 28/01/2022 07:00:09 |
Holding(s) in Company |
Download |
| 19/01/2022 12:56:06 |
Director/PDMR Shareholding |
Download |